Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1188265-31-7 | MDL No. : | MFCD10565954 |
Formula : | C11H19NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DXHPWDBZWRHQRX-UHFFFAOYSA-N |
M.W : | 229.27 | Pubchem ID : | 57363786 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.82 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 62.68 |
TPSA : | 55.84 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.31 cm/s |
Log Po/w (iLOGP) : | 2.54 |
Log Po/w (XLOGP3) : | 0.55 |
Log Po/w (WLOGP) : | 0.83 |
Log Po/w (MLOGP) : | 0.22 |
Log Po/w (SILICOS-IT) : | 0.8 |
Consensus Log Po/w : | 0.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.34 |
Solubility : | 10.4 mg/ml ; 0.0453 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.29 |
Solubility : | 11.6 mg/ml ; 0.0507 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.3 |
Solubility : | 11.5 mg/ml ; 0.0504 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.92 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 83863-72-3 ]
Ethyl 3-methoxy-4-oxopiperidine-1-carboxylate
Similarity: 0.97
[ 83863-72-3 ]
Ethyl 3-methoxy-4-oxopiperidine-1-carboxylate
Similarity: 0.97
[ 1130156-23-8 ]
tert-Butyl 3-hydroxy-4-oxopiperidine-1-carboxylate
Similarity: 0.95
[ 1228600-46-1 ]
tert-Butyl 2-acetylmorpholine-4-carboxylate
Similarity: 0.92
[ 1408076-29-8 ]
3-Boc-6-oxa-3-azabicyclo[3.2.1]octane-8-one
Similarity: 0.88
[ 1251000-29-9 ]
tert-Butyl 1-oxo-6-oxa-9-azaspiro[4.5]decane-9-carboxylate
Similarity: 0.88
[ 83863-72-3 ]
Ethyl 3-methoxy-4-oxopiperidine-1-carboxylate
Similarity: 0.97
[ 1130156-23-8 ]
tert-Butyl 3-hydroxy-4-oxopiperidine-1-carboxylate
Similarity: 0.95
[ 1228600-46-1 ]
tert-Butyl 2-acetylmorpholine-4-carboxylate
Similarity: 0.92
[ 1408076-29-8 ]
3-Boc-6-oxa-3-azabicyclo[3.2.1]octane-8-one
Similarity: 0.88
[ 1251000-29-9 ]
tert-Butyl 1-oxo-6-oxa-9-azaspiro[4.5]decane-9-carboxylate
Similarity: 0.88
[ 83863-72-3 ]
Ethyl 3-methoxy-4-oxopiperidine-1-carboxylate
Similarity: 0.97
[ 1130156-23-8 ]
tert-Butyl 3-hydroxy-4-oxopiperidine-1-carboxylate
Similarity: 0.95
[ 1160246-89-8 ]
tert-Butyl 3-oxo-1-oxa-7-azaspiro[4.5]decane-7-carboxylate
Similarity: 0.88